Whitepaper
11 Mar 2026

Investing in Form-Fill-Seal technology

PDF 82 kB

Extensive process understanding is required to ensure the consistent manufacture of high-quality sterile parenteral products. At Grifols, our use of state-of-the-art automated aseptic processing systems, including form-fill-seal (FFS) technology, ensures control with minimal human intervention.

Content provided by our supplier

Grifols International, S.A.

  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis

Other Content from Grifols International, S.A. (19)